{"entity":{"type":"insider","cik":"0001861926","url":"/insider/0001861926","json_url":"/insider/0001861926.json","name":"SAHA SAURABH","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":22,"first":"2021-11-18","last":"2025-07-21","span_basis":"filed_date"},"name_variants":[{"name":"SAHA SAURABH","source":"filing","n_filings":22,"first_seen":"2021-11-18","last_seen":"2025-07-21"}],"transactions":[{"id":4825968,"accession":"0001847903-25-000119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000119","line_url":"/filing/0001847903-25-000119#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":15.92,"price_display":"15.92","price_state":"stated","total_value":875600.0,"total_display":"875,600.00","total_whole":"875,600","shares_owned_after":221017.0,"shares_owned_after_display":"221,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-21","scope":"insider"},{"id":4686263,"accession":"0001847903-25-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000095","line_url":"/filing/0001847903-25-000095#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":12.6332,"price_display":"12.63","price_state":"stated","total_value":694826.0,"total_display":"694,826.00","total_whole":"694,826","shares_owned_after":221017.0,"shares_owned_after_display":"221,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-20","filed_date":"2025-06-20","scope":"insider"},{"id":4971965,"accession":"0001847903-25-000076","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000076","line_url":"/filing/0001847903-25-000076#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":12.7111,"price_display":"12.71","price_state":"stated","total_value":699110.5,"total_display":"699,110.50","total_whole":"699,111","shares_owned_after":221017.0,"shares_owned_after_display":"221,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-20","scope":"insider"},{"id":4779416,"accession":"0001847903-25-000055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000055","line_url":"/filing/0001847903-25-000055#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40344.0,"shares_display":"40,344","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":501475.92,"total_display":"501,475.92","total_whole":"501,476","shares_owned_after":221017.0,"shares_owned_after_display":"221,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-22","filed_date":"2025-04-22","scope":"insider"},{"id":4779408,"accession":"0001847903-25-000055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-25-000055","line_url":"/filing/0001847903-25-000055#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14656.0,"shares_display":"14,656","price_per_share":12.2885,"price_display":"12.29","price_state":"stated","total_value":180100.256,"total_display":"180,100.26","total_whole":"180,100","shares_owned_after":261361.0,"shares_owned_after_display":"261,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-21","filed_date":"2025-04-22","scope":"insider"},{"id":4644332,"accession":"0001847903-25-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-25-000045","line_url":"/filing/0001847903-25-000045#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":16.692,"price_display":"16.69","price_state":"stated","total_value":918060.0,"total_display":"918,060.00","total_whole":"918,060","shares_owned_after":276017.0,"shares_owned_after_display":"276,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":5219200,"accession":"0001764046-25-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764046-25-000026","line_url":"/filing/0001764046-25-000026#line-1","is_derivative":false,"issuer_cik":"0001764046","issuer_name":"CLARIVATE PLC","issuer_ticker":"CLVT","issuer_name_source":null,"issuer_url":"/issuer/0001764046","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":58275.0,"shares_display":"58,275","price_per_share":4.36,"price_display":"4.36","price_state":"stated","total_value":254079.0,"total_display":"254,079.00","total_whole":"254,079","shares_owned_after":82016.0,"shares_owned_after_display":"82,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":4396985,"accession":"0001847903-25-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000035","line_url":"/filing/0001847903-25-000035","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":15.928871590909091,"price_display":"15.93","price_state":"stated","total_value":876087.9375,"total_display":"876,087.94","total_whole":"876,088","shares_owned_after":331792.0,"shares_owned_after_display":"331,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-20","filed_date":"2025-02-20","scope":"insider","n_lines":2},{"id":4187351,"accession":"0001847903-25-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000011","line_url":"/filing/0001847903-25-000011","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":15.771455227272726,"price_display":"15.77","price_state":"stated","total_value":867430.0375,"total_display":"867,430.04","total_whole":"867,430","shares_owned_after":431023.0,"shares_owned_after_display":"431,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-22","scope":"insider","n_lines":2},{"id":2333621,"accession":"0001847903-24-000186","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000186","line_url":"/filing/0001847903-24-000186#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":17.4374,"price_display":"17.44","price_state":"stated","total_value":959057.0,"total_display":"959,057.00","total_whole":"959,057","shares_owned_after":520661.0,"shares_owned_after_display":"520,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-20","scope":"insider"},{"id":2134485,"accession":"0001847903-24-000178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000178","line_url":"/filing/0001847903-24-000178#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":87496.0,"shares_display":"87,496","price_per_share":18.4609,"price_display":"18.46","price_state":"stated","total_value":1615254.9064,"total_display":"1,615,254.91","total_whole":"1,615,255","shares_owned_after":575661.0,"shares_owned_after_display":"575,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-06","scope":"insider"},{"id":2573993,"accession":"0001847903-24-000175","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000175","line_url":"/filing/0001847903-24-000175#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":299.0,"shares_display":"299","price_per_share":18.23,"price_display":"18.23","price_state":"stated","total_value":5450.77,"total_display":"5,450.77","total_whole":"5,451","shares_owned_after":575661.0,"shares_owned_after_display":"575,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"},{"id":2134482,"accession":"0001847903-24-000171","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001847903-24-000171","line_url":"/filing/0001847903-24-000171#line-5","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1671.0,"shares_display":"1,671","price_per_share":18.2396,"price_display":"18.24","price_state":"stated","total_value":30478.3716,"total_display":"30,478.37","total_whole":"30,478","shares_owned_after":575661.0,"shares_owned_after_display":"575,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-22","scope":"insider"},{"id":2134478,"accession":"0001847903-24-000171","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001847903-24-000171","line_url":"/filing/0001847903-24-000171#line-3","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3511.0,"shares_display":"3,511","price_per_share":18.2365,"price_display":"18.24","price_state":"stated","total_value":64028.3515,"total_display":"64,028.35","total_whole":"64,028","shares_owned_after":575661.0,"shares_owned_after_display":"575,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2024-11-22","scope":"insider"},{"id":2134474,"accession":"0001847903-24-000171","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000171","line_url":"/filing/0001847903-24-000171#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":16.8858,"price_display":"16.89","price_state":"stated","total_value":928719.0,"total_display":"928,719.00","total_whole":"928,719","shares_owned_after":575661.0,"shares_owned_after_display":"575,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-22","scope":"insider"},{"id":2809740,"accession":"0001847903-24-000169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000169","line_url":"/filing/0001847903-24-000169#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32023.0,"shares_display":"32,023","price_per_share":18.2812,"price_display":"18.28","price_state":"stated","total_value":585418.8676,"total_display":"585,418.87","total_whole":"585,419","shares_owned_after":630661.0,"shares_owned_after_display":"630,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-13","filed_date":"2024-11-15","scope":"insider"},{"id":2051017,"accession":"0001847903-24-000160","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001847903-24-000160","line_url":"/filing/0001847903-24-000160#line-3","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2592.0,"shares_display":"2,592","price_per_share":15.3151,"price_display":"15.32","price_state":"stated","total_value":39696.7392,"total_display":"39,696.74","total_whole":"39,697","shares_owned_after":630661.0,"shares_owned_after_display":"630,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-23","filed_date":"2024-10-23","scope":"insider"},{"id":2051016,"accession":"0001847903-24-000160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000160","line_url":"/filing/0001847903-24-000160#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30203.0,"shares_display":"30,203","price_per_share":15.6663,"price_display":"15.67","price_state":"stated","total_value":473169.2589,"total_display":"473,169.26","total_whole":"473,169","shares_owned_after":633253.0,"shares_owned_after_display":"633,253","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-22","filed_date":"2024-10-23","scope":"insider"},{"id":2051014,"accession":"0001847903-24-000160","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000160","line_url":"/filing/0001847903-24-000160#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22205.0,"shares_display":"22,205","price_per_share":15.801,"price_display":"15.80","price_state":"stated","total_value":350861.205,"total_display":"350,861.20","total_whole":"350,861","shares_owned_after":663456.0,"shares_owned_after_display":"663,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-21","filed_date":"2024-10-23","scope":"insider"},{"id":2261326,"accession":"0001847903-24-000145","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000145","line_url":"/filing/0001847903-24-000145#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55000.0,"shares_display":"55,000","price_per_share":16.527,"price_display":"16.53","price_state":"stated","total_value":908985.0,"total_display":"908,985.00","total_whole":"908,985","shares_owned_after":721924.0,"shares_owned_after_display":"721,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-20","filed_date":"2024-09-20","scope":"insider"},{"id":2072498,"accession":"0001847903-24-000142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000142","line_url":"/filing/0001847903-24-000142#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":175000.0,"shares_display":"175,000","price_per_share":16.5247,"price_display":"16.52","price_state":"stated","total_value":2891822.5,"total_display":"2,891,822.50","total_whole":"2,891,823","shares_owned_after":776924.0,"shares_owned_after_display":"776,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2099010,"accession":"0001764046-24-000122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001764046-24-000122","line_url":"/filing/0001764046-24-000122#line-1","is_derivative":false,"issuer_cik":"0001764046","issuer_name":"CLARIVATE PLC","issuer_ticker":"CLVT","issuer_name_source":null,"issuer_url":"/issuer/0001764046","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17646.0,"shares_display":"17,646","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":119110.5,"total_display":"119,110.50","total_whole":"119,111","shares_owned_after":23741.0,"shares_owned_after_display":"23,741","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-30","filed_date":"2024-09-04","scope":"insider"},{"id":3145771,"accession":"0001847903-24-000137","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000137","line_url":"/filing/0001847903-24-000137#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46651.0,"shares_display":"46,651","price_per_share":12.3021,"price_display":"12.30","price_state":"stated","total_value":573905.2671,"total_display":"573,905.27","total_whole":"573,905","shares_owned_after":776924.0,"shares_owned_after_display":"776,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-23","scope":"insider"},{"id":3191069,"accession":"0001847903-24-000131","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001847903-24-000131","line_url":"/filing/0001847903-24-000131#line-3","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":506.0,"shares_display":"506","price_per_share":12.23,"price_display":"12.23","price_state":"stated","total_value":6188.38,"total_display":"6,188.38","total_whole":"6,188","shares_owned_after":823575.0,"shares_owned_after_display":"823,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-22","scope":"insider"},{"id":3191064,"accession":"0001847903-24-000131","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000131","line_url":"/filing/0001847903-24-000131#line-2","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3674.0,"shares_display":"3,674","price_per_share":12.2453,"price_display":"12.25","price_state":"stated","total_value":44989.2322,"total_display":"44,989.23","total_whole":"44,989","shares_owned_after":824081.0,"shares_owned_after_display":"824,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-22","scope":"insider"},{"id":3191060,"accession":"0001847903-24-000131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000131","line_url":"/filing/0001847903-24-000131#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4169.0,"shares_display":"4,169","price_per_share":12.3215,"price_display":"12.32","price_state":"stated","total_value":51368.3335,"total_display":"51,368.33","total_whole":"51,368","shares_owned_after":827755.0,"shares_owned_after_display":"827,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-20","filed_date":"2024-08-22","scope":"insider"},{"id":6841129,"accession":"0000899243-22-024303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024303","line_url":"/filing/0000899243-22-024303#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":4.6284,"price_display":"4.63","price_state":"stated","total_value":46284.0,"total_display":"46,284.00","total_whole":"46,284","shares_owned_after":38000.0,"shares_owned_after_display":"38,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-27","scope":"insider"},{"id":6116817,"accession":"0000899243-22-004782","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-004782","line_url":"/filing/0000899243-22-004782#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":9.74,"price_display":"9.74","price_state":"stated","total_value":48700.0,"total_display":"48,700.00","total_whole":"48,700","shares_owned_after":28000.0,"shares_owned_after_display":"28,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-02","filed_date":"2022-02-04","scope":"insider"},{"id":5491931,"accession":"0000899243-21-045311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-045311","line_url":"/filing/0000899243-21-045311#line-1","is_derivative":false,"issuer_cik":"0001847903","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001847903","owner_cik":"0001861926","owner_name":"SAHA SAURABH","owner_display_name":"SAHA SAURABH","owner_url":"/insider/0001861926","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23000.0,"shares_display":"23,000","price_per_share":12.2814,"price_display":"12.28","price_state":"stated","total_value":282472.2,"total_display":"282,472.20","total_whole":"282,472","shares_owned_after":23000.0,"shares_owned_after_display":"23,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-16","filed_date":"2021-11-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Director, Officer (Chief Executive Officer)","n_filings":20,"first_seen":"2021-11-18","last_seen":"2025-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001764046","name":"CLARIVATE PLC","url":"/issuer/0001764046","role":"Director","n_filings":2,"first_seen":"2024-09-04","last_seen":"2025-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001861926","retrieved_at":"2026-08-26T18:04:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}